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The monoclonal antibody ER-BMDMl recognizes 
a macrophage and dendritic cell differentiation 
antigen with aminopeptidase activity* 
Here we describe the reactivity of monoclonal antibody (mAb) ER-BMDM1, 
directed against a 160-kDa cell membrane-associated antigen (Ag) with amino- 
peptidase activity. The aminopeptidase recognized by ER-BMDMI is present on 
various mouse macrophage (MQ) and dendritic cell (DC) subpopulations as well 
as on microvillous epithelia. Analysis of ER-BMDM1 Ag expression in in vitro 
models of M a  maturation revealed that the Ag is expressed at increasing levels 
upon maturation of MQ. In vivo, high level expression of the ER-BMDM1 Ag 
occurs after the monocytic stage of maturation, since bone marrow cells and 
peripheral blood monocytes are essentially ER-BMDM1 negative. Analysis of 
isolated-resident and elicited MQ populations showed that ER-BMDMI recog- 
nizes a specific subpopulation of mature M a :  only some resident peritoneal and 
alveolar MQ are ER-BMDM1 positive, whereas virtually all thioglycollate- 
elicited peritoneal exudate M a  bind the mAb. In lymphoid organs, a subpopu- 
lation of MQ is recognized as well as interdigitating cells (IDC) located in T cell 
areas. Phenotypic analysis of isolated DC - the in vitro equivalents of IDC - from 
spleen and lymph nodes confirmed that the majority of this important antigen- 
presenting cell population expresses the ER-BMDMI aminopeptidase. The 
molecular characteristics of the ER-BMDM1 Ag suggest that it may represent the 
mouse homolog of human CD13. 
1 Introduction 
Mature mononuclear phagocytes comprise a very hetero- 
geneous BM-derived cell population. The various represen- 
tatives perform divergent functions, such as Ag presenta- 
tion, phagocytosis of senescent cells, and killing of harmful 
microorganisms and tumor cells (reviewed in [ 1-31). Most 
of these functions have been studied using in vitro assays on 
isolated populations and/or cultured cells. It remains 
difficult, however, to ascribe these functions to specific M a  
subpopulations located in different tissue compartments. 
Therefore, a detailed characterization of M a  heterogene- 
ity in situ is needed, using markers that are specifically 
indicative of particular M a  functions. 
mAb directed against M a  Ag greatly facilitate defining 
different M a  subpopulations. For instance, ER-TR9 and 
MOMA-1 recognize two M a  subpopulations in the spleen, 
located at the marginal zone and at the inner border of the 
marginal sinus, respectively [4, 51. Other mAb, such as 
F4/80, BM8 or MOMA-2, show broader specificity, yet fail 
to detect particular MQ subpopulations [6-91. 
In this report we define a new subpopulation of mature 
mouse M a ,  characterized by the binding of mAb ER- 
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BMDM1. A significant subpopulation of dendrocytes - i .e. 
Langerhans cells, veiled cells, interdigitating cells (IDC) 
and their in vitro equivalents, dendritic cells (DC) [lo] - is 
also ER-BMDMI positive. Biochemical analysis of the 
ER-BMDMI Ag demonstrates that it is a 160-kDa protein 
which exhibits aminopeptidase activity. 
2 Materials and methods 
2.1 Animals, mAb and conjugates 
Male and female BALB/c mice were bred at our facility 
under clean, routine conditions and killed at 10-20 weeks 
of age. A female F1 (Louvain x Lewis) rat was immunized 
(see below) and killed as donor of immune spleen cells. 
As sources of mAb we used undiluted hybridoma culture 
supernatants, optimally diluted ascites fluid, or reconsti- 
tuted purified mAb (BMA Biomedicals AG, Augst, Swit- 
zerland). In addition to the ER-BMDMI mAb, described 
below, we used BM8 (anti-MQ; [S]), ER-MP20 (anti-MQ 
precursor; [Ill), ER-TR9 (anti-Ma; [4]), F4/80 (anti-Ma; 
[6]), H129.19 (anti-CD4; [12]); M3/38 (anti-Mac-2 M a  Ag; 
[13]), MOMA-1 (anti-MQ; [S]), MOMA-2 (anti-Ma; [9]), 
NLDC-145 (anti-IDC/DC; [14]), and RA3 6B2 (anti-B-220 
B cell Ag; [IS]). 
The hybridoma producing mAb ER-BMDM1 (Erasmus 
University Rotterdam-BM-derived M a ;  IgGza subclass) 
was generated essentially as described before [ I l l ,  using 
M a  obtained after 7 days from M-CSF stimulated BM 
culture [16] as the immunogen and rat Y3-Ag1.2.3 myelo- 
ma cells as the fusion partner. 
The conjugates used in this study were anti-rat Ig coupled to 
p-galactosidase (Radiochemical Centre, Amersham, GB or 
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Zymed Laboratories, San Francisco, CA; used in ELISA), 
anti-rat Ig coupled to horseradish peroxidase (Dako, 
Copenhagen, Denmark; used in immunohistology), and 
FITC-coupled F(ab')Z fragments of rabbit anti-rat IgG 
(Cappel, Malvern, PA; used in FCM). 
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2.2 Target cells for hybridoma screening 
mAb were screened in three previously described models of 
MQ maturation for the recognition of maturation-stage 
related Ag: (a) a panel of MQ cell lines, ordered in a linear 
maturation sequence [17]; (b) immature and mature 
BMDM, isolated from macrophage (M)-CSF-stimulated 
BM cultures after 4 and 7 days, respectively [ l l ,  161; (c) 
induction of maturation of the MQ precursor hybrid ROC2 
using mouse post-LPS serum + IFNy [ l l ,  161. 
In addition, ER-BMDM1 mAb was characterized by 
binding to several freshly isolated cell populations. BM cell 
suspensions were prepared in HBSS + 5 YO FCS by grinding 
femora and tibiae using a mortar. Peripheral blood 
nucleated cells were obtained after lysis of E by a 10-min 
incubation at 4°C in 17 mM Tris-HC1, pH 7.2 containing 
144 mM NH4Cl.We obtained resident peritoneal and alveo- 
lar cells by lavage, using serum-free DMEM and PBS + 0.6 
mM EDTA, respectively. PEC were isolated at 18 h and 
4 days after i.p. injection of 1 ml Brewer's thioglycollate 
medium (Difco, Detroit, MI). These popoulations were 
highly enriched for polymorphonuclear cells (PMN) and 
MQ, respectively. DC were isolated from LN and spleen as 
described previously [MI. 
2.3 ELISA, immunofluorescence labeling and FCM 
analysis 
Expression of ER-BMDM1 Ag by MQ cell lines and BM- 
DM was quantified by a fluorescence micro-ELISA inTera- 
saki trays as described earlier [16]. 
Labeling procedures for immunofluorescence and FCM 
analysis were performed essentially as described [ l l ,  191. 
mAb binding to cells was quantified by comparison of the 
obtained fluorescence values with those from quantitative 
fluorescent microbead standards (Becton Dickinson, Sun- 
nyvale, CA). Resident peritoneal MQ were identified in the 
lavage mixture on the basis of their forward- and perpen- 
dicular light-scatter characteristics. Other isolated cell 
populations were analyzed as total populations. 
2.4 Immunoperoxidase staining of cell suspensions and 
tissue sections 
ER-BMDM1 Ag expression by isolated DC was assessed at 
the single-cell level using an immunoperoxidase assay on 
cytocentrifuge preparations [20]. Immunoperoxidase stain- 
ing of cryostat tissue sections was performed essentially as 
described by de Jong et al. [21]. A hexazotized pararosan- 
iline solution was used for tissue fixation [21]. mAb binding 
was detected using either a routine diamino-benzidine 
(DAB) visualization of peroxidase [21], or a modified 
protocol involving NiS04-supplemented DAB [22]. In the 
latter case sections were counterstained with nuclear fast 
red [22], whereas sections developed according to the 
regular DAB method were counterstained with hematoxy- 
lin. 
2.5 Biochemical characterization of the Ag 
The molecular mass of the ER-BMDM1 Ag was deter- 
mined by surface radio-iodination of cells, followed by 
specific immunoprecipitation and SDS-PAGE analysis, 
essentially as described by Pont et al. [23]. 
Aminopeptidase activity was demonstrated in lysates from 
P388D1 MQ and small intestine cells, which were obtained 
by scraping. After isolation, the cells were washed twice in 
serum-free DMEM and lysed in 1 or 2 ml30 mM TrisHC1, 
pH 8.0, 1 YO Triton X-100,150 mM NaCl for 30 min on ice. 
The lysates were cleared by centrifugation for 15 min at 
15 000 X g. Antigens were specifically immunoprecipitated 
using mAb coupled to anti-rat 1c chain (MARK-1)-coated 
Sepharose-4B beads [23]. Prior to immunoprecipitation, 
the lysates were incubated for 2 h with plain MARK-1 
beads to remove non-specifically bound proteins. The 
beads were washed three times in lysate buffer and 
incubated for 90 min with 0.21 mM leucyl-6-naphthylamide 
as aminopeptidase substrate in 200 mM phosphate buffer, 
pH 8.0, supplemented with 0.2 YO Triton X-100. The reac- 
tion was stopped by adding 400 p1 1 M NaZC03 to 10 p1 
reaction mixture. Generation of the product P-naphthyl- 
amine was monitored on a fluorometer, using an excitation 
wavelength of 340nm and an emission wavelength of 
410 nm. 
Table 1. Precipitation of aminopeptidase activity 
BMDMl 
Cells Sample 
Exp. 1 P388D1 Untreated lysate (105 cells) 
ER-BMDM1 precipitateb) 
H129.19 precipitateblc) 
Exp. 2 Small Untreated lysate (lo5 cells) 
intestine ER-BMDM1 precipitateb) 
NLDC-145 precipitatebsc) 
Exp. 3 P388D1 Untreated lysate (lo5 cells) 
Lysate + ER-BMDMld) 
Lysate + ER-MP20Cqd) 
by ER- 
APAa) 
231 
175 
4 
153 
111 
0 
161 
163 
164 
APA = aminopeptidase activity determined as generation of 
fluorescent P-naphthylamine from L-leucyl-0-naphthylamide; 
fluorescence is expressed in arbitrary units. 
MARK-1-coupled Sepharose-4B beads (40 p1 wet volume), to 
which rat mAb was linked, were incubated with excess cell 
lysate, washed and assayed for precipitated aminopeptidase 
activity. 
H129.19, NLDC-145 and ER-MP20 served as IgG2, isotype- 
matched control mAb. 
mAb was added as 5 yl ascites fluid (1 : 1 diluted in PBS) per 
50 ~1 lysate (corresponding to loh cells); after 30 min of 
incubation on ice, an aliquot from this mixture corresponding to 
lo5 cells was taken for determination of aminopeptidase 
activity. 
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3 Results 
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mAb reactivity occurs with medullary IDC and with cells 
associated with cortical and medullary capillaries. 
3.1 Biochemical characterization of the ER-BMDM1 Ag 
The aim of the present study was the developent of mAb 
against M@ which would help define functional and 
phenotypic heterogeneity of these cells. mAb ER-BMDM1 
was found to recognize an Ag on various M@ subpopula- 
tions as well as on microvillous brush borders. The latter 
finding prompted us to investigate a putative proteolytic 
function of the Ag. 
Immunoprecipitation of the ER-BMDM1 Ag from 
WR19M. 1 MQ tumor cells and subsequent SDS-PAGE 
showed that the Ag is a single polypeptide chain of 
approximately 160 kDa apparent molecular mass (data not 
shown). Using substrates for enzymes within this size 
range, we investigated whether immunopurified ER- 
BMDMl Ag possessed any proteolytic activity. Table 1 
shows that the ER-BMDM1 mAb precipitated an Ag, from 
both the P388D1 MQ cell line and small intestine cells, that 
exhibits leucine aminopeptidase activity. The mAb is, most 
likely, directed against an epitope distinct from the catalytic 
site of the enzyme, since addition of the mAb did not 
influence the observed aminopeptidase activity. 
3.2 Distribution of ER-BMDM1 aminopeptidase in situ 
3.2.1 Lymphoid organs 
In the spleen strongly ER-BMDM1-positive cells, presum- 
ably M@ [24], surround the central arteriole (Fig. la). In 
the T cell area (periarteriolar lymphocyte sheath; PALS), 
IDC and PALS MQ are stained. Scattered irregularly 
shaped cells, distinct from the marginal metallophilic M@ 
(Fig. lc), are present at the inner border of the marginal 
sinus. Immunofluorescence double labeling (not shown) 
using the IDC marker NLDC-145 and the marginal metal- 
lophilic M@ marker MOMA-1 confirmed these observa- 
tions. In the splenic red pulp, two ER-BMDM1-positive 
cell types are present. First, patches of irregularly shaped 
cells are seen at the periphery of the marginal zone 
(Fig. la). In addition to ER-BMDM1 Ag, these cells 
express BM8, F4/80, MOMA-2, and Mac-2 Ag (de Jong and 
Leenen, manuscript in preparation). Based on the cellular 
morphology, phenotype and localization, we propose to 
designate these cells as “marginal red pulp M@”. The 
second population of ER-BMDM1-positive cells in the red 
pulp is a small subpopulation of “classical” red pulp M@, 
located deeper in the red pulp. 
In the mesenteric LN stretched M@, lining the inside of the 
LN capsule are clearly ER-BMDM1 positive (Fig. le) .  
ER-BMDM1-positive IDC are easily detected in the para- 
cortex (T cell area). In the LN medulla, positive M@ are 
located primarily within the medullary cords. These cells 
are clearly distinct from the ER-TR9-positive sinus M@ (cf. 
Fig. lg  and h). 
In the thymus, cells, probably M@ [24], on the inside of the 
thymic capsule and lining the connective tissue septa show a 
variable staining pattern (Fig. 2). In the cortex and corti- 
comedullary junction, most but not all acid phosphatase- 
positive MQ are recognized by ER-BMDM1. Furthermore, 
3.2.2 Non-lymphoid organs 
Villous epithelial cells in the small intenstine are heavily 
labeled, especially at the brush border (Fig. 3a).The lamina 
propria in the villi contains only a few scattered positive 
cells. In contrast, in the large intestine the epithelial cells 
are negative, whereas the numerous M a  in the lamina 
propria are clearly positive (Fig. 3b). 
Strong ER-BMDM1 staining in the liver appears to be 
associated with the microvillous brush borders of bile 
capillaries (Fig. 3c). The acid phosphatase positive Kupffer 
cells are negative. 
In the lung, there are two ER-BMDM1-positive cell types 
(Fig. 3d). Stretched cells surround blood vessels, and, at 
lower density, bronchi. Furthermore, type-I1 pneumocytes 
that express microvilli are also positive. Most alveolar MQ 
are negative. 
3.3 ER-BMDM1 aminopeptidase expression by isolated 
DC and MQ populations 
To confirm the notion that both M@ and IDC in lymphoid 
organs are recognized by ER-BMDM1, we stained DC -the 
in v i m  equivalents of IDC - as well as various isolated M@ 
populations. LN DC, identified by positive NLDC-145 
staining and acid phosphatase activity located in a cytoplas- 
mic spot, were ER-BMDM1 positive (data not shown). 
Virtually all LN DC are positive, whereas approximately 
50 YO of the NLDC-145-positive splenic DC are recognized 
by ER-BMDM1. 
BM M@ precursors and peripheral blood monocytes 
express little ER-BMDM1 Ag (Fig. 4A). In contrast, 
approximately 60% and 30% of the M@ in the resident 
peritoneal and alveolar cell populations, respectively, rea- 
dily express this marker. Remarkably, virtually all thiogly- 
collate-elicited peritoneal exudate M@ are strongly ER- 
BMDMl positive. The small positive population present in 
the granulocytic exudate, isolated 18 h after thioglycollate 
injection, most likely represents the contribution of 
remaining resident peritoneal MQ. Together, these data 
indicate that ER-BMDM1 recognizes a particular subpo- 
pulation of DC and M@. 
3.4 ER-BMDM1 aminopeptidase expression in the 
course of MT maturation 
The observation that BM M@ precursors and peripheral 
blood monocytes expressed little ER-BMDM1 Ag 
prompted us to investigate the onset of Ag expression 
during M@ maturation in more detail. Screening of ER- 
BMDMl reactivity on a panel of MQ cell lines, arrested in 
distinct, characterized stages of maturation [ 171, revealed 
that only cell lines with mature M@ characteristics were 
recognized (Fig. 4B). In M-CSF-stimulated BM cultures, 
mAb binding was hardly detectable on nonadherent M@ 
precursors isolated after 4 days, whereas mature M@ 
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Figure 2. ER-BMDMI-positive M0 and IDC in the thymus. 
ca = capsule: C = cortex: M = medulla. Original magnification 
x 140. 
Figure 3. ER-BMDMI reactivity on frozen scctions of non- 
lymphoid organs. (a) small intestine: (b) large intestine; (c) liver; 
(d) lung: e = epithelium: Ip = lamina propria; v = venule. Origi- 
nal magnifications x 125 (a.b) and x 310 (c.d). 
isolatcd aftcr 7 days strongly expressed the ER-BMDMl 
Ag  (Fig. 4B). Similarly. the M a  precursor cell line ROC2 
[ 161 cxpresscd little Ag. but induction of maturation 
simultaneously induced expression of the ER-BMDM1 Ag 
(Ii)  c d  type 
M1 
R M B l  
RMB-3 a 
WEH-38 
WEH-3 
P"5-18 
J 7 7 4 - 1  6 
RAW264 7 
R A W 3 0 9 0  1 
W R l e M  1 
b BMDM-4 BMOM-7 
R O C 2  co 
1% PES.0 5U FN- 1 . + 1 U FN- C 
0 20 40 60 a0 1 
relative expression (AU) 
K) 
Figure 4. ( A )  ER-BMDMI Ag expression by freshly isolated cell 
populations as dctermincd by FCM.Thc percent of positive cells in 
these populations and the net mAb binding per positive cell 
rcprcscnt the mean o f  at lcast three experiments f. SD. mAb 
binding is expressed in soluble FlTC molecular equivalents 
(mol.cq.FITC). PBI = periphcral blood;TG = thioglycollate. (B) 
ER-BMDM 1 Ag expression during M0 maturation as determined 
using three maturation models. (a) A panel of Me cell lines ordered 
in ii linear diffcrcntiation sequence [17]: M0 precursor (Ml ,  
KMB-I, RMB-3). immature M@ (WEHI-3B.WEHI-3) and mature 
Mu, cell lines (PUS-1.8. 57741.6, P388DI. RAW264.7. 
RAW3OYCr.I.WRI9M. I ) ;  (b) Immature nonadhcrent M6 precur- 
sor cells. isolatcd after 4 days o f  M-CSF stimulated BM culture 
(BMDM-4) are compared to mature adherent BM-derived M0, 
isolatcd after 7 days of culture (BMDM-7); (c) Induction of 
maturation in the MO precursor hybrid ROC2 [16] by culture for 
5 days with 1 YO post-LPS scrum (PES) supplemented with 0.5 U, 
1 U o r  10 U IFN-y/ml.The level of mAb binding is determined by 
ELlSA and expressed in arbitrary units (AU), relative to an 
internal standard 1161. Data show one of three independent 
cxperimcnts with similar results. 
4 Figure 1 .  ER-BMDM1 reactivity on frozen sections of spleen and 
mesenteric LN. For comparison, serial spleen sections (a-d) were 
stained with ER-BMDM1 (a), ER-TR9 (b; marginal zone Me). 
MOMA-I (c: marginal metallophilic MQ). and RA3 682 (d: 
B-cells). ER-BMDMI stains IDC and PALS M e  in the splenic 
\\ hitc pulp atid "marginal red pulp M@" (indicated with the large 
:irrow) i n  the red pulp (RP).  The small arrow indicates the central 
arteriole: P = pcriartcriolar lymphocyte sheath: F = follicle. 
Scriiil LN sections (c.i and g.h) were stained with ER-BMDMI 
(c.g). RA3 6B2 ( f :  B cells) and EK-TR'J (11: medullary sinus Me). 
I n  the 1.N cortcx. ER-BMDMI-positive M e  occur in the c:ipsule 
(inc1ic:itcd w i t h  the arrow) and mainly outside the B cell area 
(Oc' = outer cortex). IDC' are easily distinguished in the paracor- 
tcx (Pc'). I n  the medulla. ER-BMDM I-positive M@ are associated 
mainly w i t h  the medullary cords and clearly distinct from the 
mcclullary sinus Mfi clctcctcd by  ER-TR9. Asterisks i n  (g) and (h)  
indicate the smic locations i n  serial sections. Original mngnifica- 
t ions x 125 (:I-d). x 05 (c.f) and x 245 (g.11). 
(Fig. 4B). Taking these results together, we conclude that 
the ER-BMDM1 aminopeptidase is expressed increasingly 
beyond the monocytic stage in a strict maturation-related 
man n c r. 
4 Discussion 
The data presented in this report indicate that mAb 
ER-BMDM1 binds to an aminopeptidase at the cell surface 
of mouse M a ,  D C  and microvillous epithelia. Moreover, 
the ER-BMDM1 Ag is expressed in increasing amounts as 
M a  mature beyond the monocyticstage. Our finding that - 
within the hemopoietic lineage - only DC/IDC and a M a  
subpopulation express the ER-BMDMl Ag,  contributes to 
the evidence for a close phenotypic relationship between 
1572 
these cell types [9, 20, 251. Recently published data indi- 
cate that a developmental relationship exists as well, since 
monocytes can be stimulated to  differentiate into cells with 
morphological, phenotypical and functional features of DC 
[26,27]. In  addition, stimuli which induce M a  differentia- 
tion also induce development of DC from BM precursors 
[28, 291. The observation that BM-derived DC likely pass 
through the monocytic stage during their development [29] 
is in line with our finding that ER-BMDM1 Ag expression 
significantly increases after the monocytic stage. Hence, 
our data support the view that DCIIDC belong to  the 
mononuclear phagocyte system, rather than constituting a 
separate cell lineage as suggested by others [lo, 301. 
The specific reactivity of ER-BMDM1 mAb with microvilli 
in non-lymphoid organs correlates with the demonstrated 
enzymatic activity of the recognized Ag. Most likely, the 
ER-BMDM1 Ag is identical t o  leucine aminopeptidase [31] 
and aminopeptidase N [32]. We base this identification on 
the similar linkage between M a  maturation stage and 
expression of leucine aminopeptidase [33] as well as on the 
similarity in tissue distribution of aminopeptidase N and the 
ER-BMDM1 Ag [32]. Recently it was recognized that the 
human CD13 Ag exhibits aminopeptidase N activity 
[34, 351.The similarity in both molecular mass and enzyme 
activity suggests that the Ag recognized by ER-BMDM1 is 
the mouse homolog of human CD13. However, CD13 Ag is 
expressed by immature human myeloid cells and granulo- 
cytes [36], in contrast t o  the mouse ER-BMDM1 Ag. 
Additional studies are now in progress to investigate the 
putative homology between the ER-BMDM1 aminopepti- 
dase and the CD13 Ag. 
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